longbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesLongbridge ProFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge

Sequoia Vaccines, Inc.

SQVI

----
To be listed: Dec 1, 09:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile

Overview

Sequoia Vaccines, Inc. (SQVI)

Open
--
High
--
Low
--
Prev. Close
--
Volume
0
Turnover
0
Avg Price
--
Bid/Ask Ratio
--
Amplitude
--
52wk High
--
Volume Ratio
0.00
Turnover Ratio
--
52wk Low
--
Float Mkt Cap
--
Market CapUSD
--
P/ETTM
--
P/EDynamic
--
P/EStatic
--
EPSTTM
--
EPSDynamic
--
EPSStatic
--
BVPS
--
P/B
--
Circulating Supply
0.00
Dividend YieldTTM
--
DividendTTM
--
Shares
0.00
Min lot size
1
Currency
USD

News

  • TechCrunch · Oct 21, 2026 at 05:22 PM

    Blacksmith hits unicorn valuation after Sequoia leads Series C

  • TechCrunch · Apr 17, 2026 at 02:55 AM

    New leaders, new fund: Sequoia has raised $7B to expand its AI bets

  • Unusual Whales · Feb 10, 2026 at 01:02 PM

    KDventures' portfolio company SVF Vaccines names Raheleh Nassaji as CEO to drive SVF-001 vaccine to phase 1 trials.

  • prnewswire · Jan 26, 2026 at 04:43 PM

    11:41 ET 10X Health System and Verséa Discovery Launch 10X MitoScreen™, a Next-Generation Mitochondrial Assessment Test

LongbridgeAI
© 2026 Longbridge|Terms of ServicePrivacy Policy